2C-YN: Difference between revisions

Page 1
Page 2
Content deleted Content added
Added CSID, (std)InChI, and (std)InChIkey
Moved the placement of the stub notice to the very bottom and fixed the spacing.
 
(33 intermediate revisions by 17 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{cs1 config|name-list-style=vanc}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 428958919
| Watchedfields = changed
| IUPAC_name = 1-(4-ethynyl-2,5-dimethoxyphenyl)-2-aminoethane
| verifiedrevid = 452168265
| IUPAC_name = 2-(4-ethynyl-2,5-dimethoxyphenyl)ethanamine
| image = 2C-YN_skeletal.svg
| image = 2C-YN_skeletal.svg
| width = 200
| width = 200

<!--Clinical data-->
| tradename =


<!--Identifiers-->
<!--Identifiers-->
| legal_UK = Class A
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 752982-24-4
| CAS_number = 752982-24-4
| CAS_supplemental = <BR> 633290-73-0
| PubChem =
| PubChem = 12063400
| ChemSpiderID = 26234934
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 26234934
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 5L67256F94


<!--Chemical data-->
<!--Chemical data-->
| C=12 | H=15 | N=1 | O=2
| C=12 | H=15 | N=1 | O=2
| molecular_weight = 205.252 g/mol
| smiles = COc1cc(CCN)c(OC)cc1C#C
| smiles = COc1cc(CCN)c(OC)cc1C#C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| InChI = 1/C12H15NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h1,7-8H,5-6,13H2,2-3H3
| StdInChI = 1S/C12H15NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h1,7-8H,5-6,13H2,2-3H3
| InChIKey = MLJHHYIJBZVUEA-UHFFFAOYAX
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H15NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h1,7-8H,5-6,13H2,2-3H3
| StdInChIKey = MLJHHYIJBZVUEA-UHFFFAOYSA-N
| StdInChIKey = MLJHHYIJBZVUEA-UHFFFAOYSA-N
}}
}}
'''2C-YN''' is an analogue of the [[phenethylamine]] derived hallucinogen [[2C-E]] where the ethyl group has been replaced by an ethynyl group. It has similar potency to [[2C-B]] but a short duration of action.<ref>Trachsel D. Synthesis of Novel (Phenylalkyl)amines for the Investigation of Structure-Activity Relationships. Part 3. 4-Ethynyl-2,5-dimethoxyphenethylamine (4-Ethynyl-2,5-dimethoxybenzeneethanamine; 2C-YN) ''Helvetica Chimica Acta'' 2003; 86:2754-2759.</ref>


'''2C-YN''' is an [[structural analog|analog]] of [[phenethylamine]] that can be synthesized from [[2C-I]].<ref>{{cite journal | vauthors = Trachsel D | title = Synthesis of Novel (Phenylalkyl) amines for the Investigation of Structure–Activity Relationships, Part 3: 4-Ethynyl-2,5-dimethoxyphenethylamine (= 4-Ethynyl-2, 5-dimethoxybenzeneethanamine; 2C-YN). | journal = Helvetica Chimica Acta | date = August 2003 | volume = 86 | issue = 8 | pages = 2754–2759 | doi = 10.1002/hlca.200390224 }}</ref> Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-YN, although Daniel Trachsel lists it as having a dosage of around 50mg and a duration of around 2 hours, with relatively mild psychedelic effects.<ref>{{cite book | vauthors = Trachsel D, Lehmann D, Enzensperger C | title = Phenethylamine Von der Struktur zur Funktion | page = 768 | publisher = Nachtschatten Verlag AG | date = 2013 | isbn = 978-3-03788-700-4 }}</ref>
==References==

==Legality==

===Canada===
As of October 31st, 2016; 2C-YN is a controlled substance (Schedule III) in Canada.<ref>{{cite web | title = Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines) | url = http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php | date = 4 May 2016 | work = Canada Gazette }}</ref>

== See also ==
* [[2C-AL]]
* [[2C-E]]
* [[2C-CP]]
* [[2C-V]]

== References ==
{{reflist}}
{{reflist}}


{{hallucinogen-stub}}
{{Hallucinogenic phenethylamines}}
{{Hallucinogenic phenethylamines}}


[[Category:2C (psychedelics)]]
[[Category:2C (psychedelics)]]
[[Category:Alkynes]]
[[Category:Ethynyl compounds]]


{{hallucinogen-stub}}